ESSA
is a Canada-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of prostate cancer... Read moreESSA
is a Canada-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of prostate cancer... Read more
News
Nov 14, 2025
Seeking Alpha
ESSA: Repare Therapeutics enters into definitive agreement to be acquired by xenotherapeutics
Oct 09, 2025
Investing.com
ESSA: XenoTherapeutics completes acquisition of ESSA Pharma By Investing.com
Oct 06, 2025
Investing.com
ESSA: ESSA Pharma shareholders approve acquisition by XenoTherapeutics By Investing.com
Sep 30, 2025
Benzinga
ESSA: ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
Sep 24, 2025
Seeking Alpha
ESSA: ESSA Pharma cuts shareholder payout in revised Xeno deal
Sep 10, 2025
Cision Canada
Press Release: ESSA : Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
Aug 28, 2025
FinanzNachrichten
ESSA: INVESTOR ALERT: Morris Kandinov LLP Investigating ESSA Pharma Inc. (EPIX)
Aug 25, 2025
TipRanks
ESSA: ESSA Pharma Clarifies Share Trading Period Details
Aug 13, 2025
Benzinga
ESSA: ESSA Pharma Q3 EPS $(0.09) Beats $(0.16) Esti...
Aug 06, 2025
Investing.com
ESSA: ESSA Pharma to distribute $80 million to shareholders ahead of acquisition By Investing.com
ESSA Competitors
1
2
3
4
5
6
7
8
9
10